[Limited prescribing freedom by federal cost regulation?].
The governmental budgeting of the overall expenses for medicines obviously does not impair the quality of medical treatment. But pharmaco-epidemiologic investigations are lacking. This regulation is just an instrument for diminution the health care expenses without interfering with the quality of prescription and provision of medicines.